Hydroxyzine Pamoate Capsule
Product Images NDC 51655-725

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 51655-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (238d1dcc 5db1 4e6f A75f 4cfcaa5b590a 01)

Chemical structure of hydroxyzine pamoate showing the molecular arrangement of its atoms and functional groups as two distinct linked entities representing the hydroxyzine and pamoate components.*

FDA Label Image

Image (238d1dcc 5db1 4e6f A75f 4cfcaa5b590a 02)

FDA Label Image

Label (51655 725 52 Master Bottle Label Approval Rev A 06 21)

Label for Hydroxyzine Pamoate Capsules, USP 25 mg, showing 30 capsules per container. The label indicates prescription use only and storage instructions at controlled room temperature. It states the product is tartrazine dye free and is repackaged by Northwind Pharmaceuticals, a division of Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.